The XII Cedars-Sinai Parkinson's Disease and Movement Disorders Annual Symposium

Saturday, November 7, 2026, 7:30 AM - 5:05 PM PT, Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA

Advancing Care in Parkinsons Disease and Related Movement Disorders Parkinsons disease (PD) is not only the most common movement disorder, but also one of the fastest-growing neurological conditions worldwide. According to the Parkinsons Foundation, nearly one million people in the United States are currently living with PD, and approximately 60,000 new cases are diagnosed each year. In addition to PD, a range of other movement disorders including essential tremor, dystonia, Huntingtons disease, and atypical parkinsonian syndromes present ongoing and complex challenges for clinicians and patients alike. Because these disorders are highly variable in presentation and progression, individualized and multidisciplinary care is essential. In particular, Parkinsons disease requires tailored treatment strategies that address both motor and non-motor symptoms while adapting to each patients unique needs over time. To address these challenges, expert faculty will review current advances in the diagnosis and management of movement disorders, with a primary focus on Parkinsons disease. The program will highlight both established and emerging medical and surgical therapies aimed at improving symptom control, slowing disease progression, and enhancing overall quality of life. Additional topics will include the management of cognitive, behavioral, autonomic, and psychiatric symptoms, as well as the impact of nutrition, exercise, lifestyle, and psychosocial support on comprehensive patient care. Through interactive discussion and evidence-based updates, participants will gain practical tools and clinical insights to improve outcomes for patients across the spectrum of movement disorders. This educational activity is intended for a multidisciplinary audience, including neurologists, neurosurgeons, psychiatrists, physiatrists (PM&R), internists, and primary care physicians. The program will also be valuable for nurses, nurse practitioners, physician assistants, allied health professionals, and neurology residents and fellows, as well as other healthcare providers involved in the care of individuals with Parkinsons disease and related movement disorders.

1. Recognize the clinical presentation, management and progression of Parkinsons disease and other movement disorders
2. Assess available therapies for the management of motor and nonmotor symptoms of Parkinsons disease dystonia and essential tremor
3. Evaluate ongoing and emerging research in Parkinsons disease and the implications for emerging therapeutic options
4. Guide patients and caregivers in making key treatment decisions in Parkinsons disease or other movement disorders.
5. Review the promise and benefits of Remote Therapeutic Management of Parkinson's patients

Physicians (In-person) - $230.00
All Other Healthcare Providers (In-person) - $170.00         Residents/Fellows (In-Person) - $75.00

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

AMA PRA Category 1 Credit(s)™ (MD, DO) (8.00 hours), Non-Physician AMA Attendance (8.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, November 7, 2026